• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.05 Down 0.06(2.84%) Jul 31, 4:00PM EDT
    |After Hours : 2.05 0.00 (0.00%) Jul 31, 5:36PM EDT
    Add to Portfolio
    Prev Close:2.11
    Open:2.10
    Bid:2.02 x 100
    Ask:2.12 x 1000
    1y Target Est:2.00
    Beta:-1.45
    Next Earnings Date:N/A
    Day's Range:2.01 - 2.10
    52wk Range:1.83 - 5.48
    Volume:1,700,925
    Avg Vol (3m):1,531,980
    Market Cap:191.60M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUDown 2.84%191.60M
    BIIBUp 0.56%74.97B
    GSKDown 0.34%104.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback